These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Update on the clinical utility of converting enzyme inhibitors in cardiovascular disease. November 10, 1985, Washington, D.C. Am J Med; 1986 Oct; 81(4C):1-50. PubMed ID: 3022579 [No Abstract] [Full Text] [Related]
7. Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system. Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):353-61. PubMed ID: 2991636 [No Abstract] [Full Text] [Related]
8. [Some advances in angiotensin converting enzyme inhibitors]. Jia L Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897 [No Abstract] [Full Text] [Related]
9. [Drug information. New principle in the treatment of elevated blood pressure]. Dahlerup J Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014 [No Abstract] [Full Text] [Related]
10. [Hypertension treatment 1985: significance of calcium antagonists and angiotensin-converting enzyme inhibitors]. Weidmann P Ther Umsch; 1985 Aug; 42(8):528-39. PubMed ID: 2996166 [No Abstract] [Full Text] [Related]
11. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure]. Koster M Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442 [No Abstract] [Full Text] [Related]
12. Converting-enzyme inhibition and glomerular filtration rate in essential hypertension. Bianchi MD; Fernandes M N Engl J Med; 1980 Jan; 302(3):179. PubMed ID: 6243169 [No Abstract] [Full Text] [Related]
13. [Inhibition of the renin-angiotensin system in treating arterial hypertension]. Fagard R; Leuven KU; Staessen J; Amery A Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041 [No Abstract] [Full Text] [Related]
14. Clinical utility of angiotensin converting enzyme inhibitors in hypertension. Gavras I; Gavras H Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition: a new therapeutic modality. Gavras H; Charocopos F; Brunner H; Gavras I Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426 [No Abstract] [Full Text] [Related]
17. Angiotensin converting enzyme inhibitors in the treatment of hypertension. Materson BJ Compr Ther; 1983 Oct; 9(10):14-20. PubMed ID: 6196149 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention. Cooke HM; De Besse A Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361 [TBL] [Abstract][Full Text] [Related]
19. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C; Cosentino E; De Sanctis D Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921 [TBL] [Abstract][Full Text] [Related]